Abstract
ancer is by far the most common targeted disease for gene therapy. Conventional cancer treatments such as surgery, chemotherapy, radiotherapy, and hormone therapy all suffer from various shortcomings, although they could be effective for some cancers. These include limited specificity, nonresponsiveness to therapy, nonspecific side effects, and recurrence due to incomplete eradication of cancerous cells. All these limitations emphasize the need for alternative therapy with high effectiveness, specificity, and minimal side effects. Cancer gene therapy is believed to meet these requirements.
Original language | English (US) |
---|---|
Title of host publication | Pharmaceutical Gene Delivery Systems |
Publisher | CRC Press |
Pages | 279-319 |
Number of pages | 41 |
ISBN (Electronic) | 9780203912331 |
ISBN (Print) | 9780824742355 |
State | Published - Jan 1 2003 |
Externally published | Yes |
ASJC Scopus subject areas
- General Medicine
- General Biochemistry, Genetics and Molecular Biology